ACI-Charleston Program Registration
Registration for this event is closed. February 24, 2018 Program
Offers up to 5.5 AMA PRA Category 1 Credits™
7:00 – 8:00 a.m.
Check-in, Onsite Registration and Networking
Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice
Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy
8:00 – 8:05 a.m.
Welcome, Introduction, and Pretest Questions by the Society for Immunotherapy of Cancer
8:05 – 8:35 a.m.
Basic Principles of Cancer ImmunotherapyEric C. Bartee, PhD – Medical University of South Carolina
8:35 – 8:55 a.m.
Immunotherapy for the Treatment of MelanomaChrystal M. Paulos, PhD – MUSC Hollings Cancer Center
8:55 – 9:15 a.m.
Immunotherapy for the Treatment of Lung CancerMark Rubinstein, MD – MUSC Hollings Cancer Center
9:15 – 9:35 a.m.
Immunotherapy for the Treatment of Genitourinary CancersTheodore S. Gourdin, MD – MUSC Hollings Cancer Center
9:35 – 9:55 a.m
Immunotherapy for the Treatment of Hematologic MalignanciesZihai Li, MD, PhD – MUSC Hollings Cancer Center
9:55 – 10:15 a.m
Immunotherapy for the Treatment of Head and Neck CancersDavid M. Neskey, MD – MUSC Hollings Cancer Center
10:15 – 10:25 a.m
Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice
10:25 – 10:30 a.m.
Information About the Society for Immunotherapy of Cancer Resources
10:30 – 11:00 a.m.
Effective Practices for Incorporating Immunotherapy Into Hospital OperationsUna Hopkins, RN, FNP-BC, DNP – White Plains Hospital, Dickstein Cancer Treatment Center
11:00 – 11:30 a.m.
Coverage and Reimbursement Challenges and StrategiesUna Hopkins, RN, FNP-BC, DNP – White Plains Hospital, Dickstein Cancer Treatment Center
11:30 – 11:35 a.m.
Take-Home Points for Part A
11:35 a.m. – noon
Part B: Immune-Related Adverse Event (irAE) Management
noon – 12:20 p.m.
Mechanisms of Immune-Related Adverse EventsMark P. Rubinstein, MD, FACS – Medical University of South Carolina
12:20 – 12:50 p.m.
Nursing Perspective on irAEs: Patient Education, Monitoring and ManagementMichelle Taffaro-Neskey, PA-C – MUSC Hollings Cancer Center
12:50 – 1:20 p.m.
Management and Mitigation of irAEs for Immunotherapy PrescribersJohn M. Kaczmar, MD – MUSC Hollings Cancer Center
1:20 – 1:50 p.m.
Identification and Management of Immune-Related Adverse Events in the Emergency SettingWilliam T. Durkin Jr., MD – American Academy of Emergency Medicine
1:50 – 1:55 p.m.
Posttest Questions by the Society for Immunotherapy of Cancer
1:55 – 2:00 p.m.
Take-Home Points for Part B and Closing Remarks
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these six-hour programs will facilitate understanding of:
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through two post-program webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice. Breakfast and lunch will be served at the live portion of this event.
For more information, including program objectives, click here.This program is presented in collaboration with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC).
Continuing Education Info
Download PDF Flyer
As a benefit of program attendance, stay connected with regional experts and program attendees at the post-program webinars. The post-program webinars are a chance to ask questions and receive guidance from program organizers. The following are dates and other information for ACI-Charleston post-program webinars:
Upon registration for the ACI-Charleston program, visit the program's online community for links to access these webinars.
Participation in this free online preprogram class is strongly recommended as it contains information that will not be covered at the program on Feb. 24.
This interactive class provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program.
Click here to access this free class.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org